Feeling Through the Patient’s Eyes: Delivering the Diagnosis of Glaucoma as a Therapeutic Intervention Authors: Leticia A Checo, Syril Dorairaj Published: 2026 ABSTRACT AbstractGlaucoma is a chronic, progressive optic neuropathy; however, receiving the diagnosis represents more than a clinical event. For many patients, it is a psychological turning point associated with fear of blindness, loss of independence, and becoming a burden, regardless of disease stage. Psychological distress, health beliefs, communication, and treatment adherence are closely interconnected in glaucoma care, although the specific effect of the diagnostic conversation has not yet been prospectively established. In this Perspective article, we propose that delivering a glaucoma diagnosis should be approached as a therapeutic intervention. Adapting structured communication strategies such as the SPIKES protocol to glaucoma may support patient understanding, emotional processing, trust, and long-term engagement. The framework is applied to glaucoma-specific challenges, including asymptomatic disease, interpretation of optical coherence tomography and visual field findings, chronic topical therapy, and lifelong follow-up. It is presented as an evidence-informed clinical approach rather than a validated substitute for treatment. Recognizing the emotional and social dimensions of glaucoma offers a practical opportunity to strengthen patient-centered care in routine ophthalmic practice, while prospective studies are needed to evaluate its effect on distress, adherence, follow-up, and clinical outcomes.Keywords: glaucoma, physician–patient communication, treatment adherence, quality of life, SPIKES protocol, vision loss, psychological impact, empathy, ophthalmology Introduction “Doctor, am I going to be blind?” Commonly, this is the first question. At that moment, the patient is usually not interested in intraocular pressure, retinal nerve fiber layer thickness, visual field indices, or treatment options. For patients, a glaucoma diagnosis is not defined only by clinical parameters, but by what it appears to represent: their future. Glaucoma is commonly described as a silent disease: progressive, painless, and frequently asymptomatic in its early stages. But the moment of diagnosis is rarely silent. Fear of blindness is common among newly diagnosed patients, and the burden of glaucoma extends beyond measurable visual loss to include uncertainty, treatment burden, and changes in quality of life.1–3 The way this diagnosis is communicated may shape how patients understand the disease, engage with treatment, and live with glaucoma afterward. International glaucoma guidelines emphasize preservation of visual function and quality of life, patient education, adherence, incorporation of patient preferences, and the importance of communication and psychological support.4,5 Structured approaches to difficult conversations, particularly SPIKES and related communication training, have also been discussed in ophthalmology.6,7 However, these approaches are not routinely embedded in glaucoma care, and there is no widely adopted, prospectively validated framework specifically designed for delivering a glaucoma diagnosis. This Perspective proposes that the diagnostic conversation should be recognized as more than an informational task. It may be the first therapeutic intervention in the patient’s lifelong glaucoma journey: not because words replace pressure-lowering treatment, but because the way we communicate can support understanding, emotional adaptation, and sustained engagement with care. Approach to This Perspective This article is a narrative Perspective informed by a targeted review of the published literature. PubMed/MEDLINE was searched through July 2026 using combinations of the terms glaucoma, diagnosis, communication, breaking bad news, SPIKES, adherence, health literacy, shared decision-making, anxiety, depression, quality of life, and patient-centered care. Relevant reference lists and international glaucoma guidelines were also reviewed. Priority was given to glaucoma-specific studies, systematic reviews, major guidelines, and communication or adherence interventions. This was not a systematic review; no prespecified protocol, duplicate screening, or formal risk-of-bias assessment was performed. The Psychological Dimension of Glaucoma The burden of glaucoma extends beyond structural and functional damage. Emotional responses to diagnosis are common and may include fear, anxiety, sadness, and uncertainty about the future. Fear of blindness can be present even when useful vision is preserved and the disease is in an early stage.1–3 Psychological distress has also been associated with treatment behavior and glaucoma-related outcomes. Greater glaucoma-related distress has predicted lower medication adherence, while anxiety and depression have been associated with measures of disease progression in observational studies.8,9 These relationships are complex and do not prove that distress directly causes progression. They do, however, demonstrate that emotional health is clinically relevant rather than separate from glaucoma management. The patient does not receive the diagnosis in isolation from previous experiences. A relative who became blind, a history of medical loss, low health literacy, financial limitations, difficulty administering drops, or dependence on others for transportation can alter the meaning of the same clinical findings. Conversely, a patient who still sees well may underestimate the disease because there is no pain or perceived change. These findings suggest that the way patients process the diagnosis may be almost as important as the information itself. Communication as a Determinant of Engagement Despite its impact, the delivery of a glaucoma diagnosis is often approached as a purely informational task. In reality, it is a moment that may influence patient behavior. Patients who understand glaucoma as inevitable blindness may become emotionally paralyzed or disengaged; those who understand their individual risk, the purpose of treatment, and the plan for follow-up may be better prepared to participate in care. Adherence is multifactorial. Cost, side effects, regimen complexity, forgetfulness, manual dexterity, access to care, and the asymptomatic nature of glaucoma all matter.10–12 Communication cannot solve every barrier; however, studies have associated physician-patient communication, disease knowledge, self-efficacy, and health literacy with glaucoma medication adherence.10,11,13,14 More recently, a randomized clinical trial showed that personalized glaucoma coaching improved medication adherence and reduced glaucoma-related distress compared with standard written education.15 This does not validate SPIKES at the moment of diagnosis, but it supports the broader principle that structured, individualized communication can influence clinically relevant behavior. Communication is therefore not neutral. It can support the patient’s capacity to engage with treatment, or unintentionally make that engagement more difficult. Adapting the SPIKES Protocol to Glaucoma Care The SPIKES protocol, developed by Baile, Buckman et al for difficult conversations in oncology, provides a six-step framework: Setting, Perception, Invitation, Knowledge, Emotions, and Strategy and Summary.16 Its principles are highly applicable to ophthalmology, and previous work has specifically explored the use of SPIKES when communicating glaucoma and other sight-threatening diagnoses.6,7 Glaucoma is not cancer, and the framework should not simply be transferred without adaptation. In oncology, difficult news may involve a discrete diagnosis, recurrence, or treatment failure. In glaucoma, the challenge is often to explain a chronic and frequently asymptomatic disease through probabilistic findings accumulated over time. A patient may see an abnormal optical coherence tomography (OCT) image before noticing any functional limitation, or may have visual field loss while still reading the smallest line on the visual acuity chart. Treatment may reduce future risk without producing an immediate sensation of benefit. In glaucoma, the diagnosis is both medical information and an emotional event. Communication should therefore be intentional, structured, and therapeutic. Table 1 provides a practical overview of how each step of the SPIKES protocol can be applied in glaucoma care. Table 1Glaucoma-Specific Application of the SPIKES FrameworkComponentGlaucoma-Specific TaskIllustrative LanguageSettingProtect privacy, reduce interruptions, sit at eye level, and include a support person with permission.“Before we review the tests, is there anyone you would like to have with you?”PerceptionExplore prior knowledge, family experiences, fear of blindness, and the mismatch between absent symptoms and objective damage.“What have you heard about glaucoma, and what worries you most?”InvitationAsk how much detail the patient wants and whether to begin with an overview, images, or a stepwise explanation.“Would you prefer the main message first, or should we review the OCT and visual field step by step?”KnowledgeExplain optic nerve damage, OCT and visual field findings, uncertainty, treatment goals, and lifelong monitoring in plain language; use teach-back.“This does not mean blindness is inevitable, but it tells us that we should reduce your risk and monitor change”.EmotionsName and validate fear or sadness; pause; avoid false reassurance; offer individualized, credible hope.“I can see that this is frightening. Let us talk about what these findings mean for you and what we can do next”.Strategy and SummaryAgree on treatment and follow-up; address technique, side effects, cost, barriers, and support; provide a written plan.“Let us agree on the next step. Please tell me in your own words what the plan is”.Note: These examples are prompts rather than scripts and should be adapted to the patient’s clinical status, language, culture, health literacy, and preferences. Glaucoma-Specific Application of the SPIKES Framework Note: These examples are prompts rather than scripts and should be adapted to the patient’s clinical status, language, culture, health literacy, and preferences. S - Setting Up the Conversation The setting in which a diagnosis is delivered shapes how the patient experiences and remembers the conversation. Whenever possible, physicians should provide privacy, minimize interruptions, sit at eye level, and maintain direct eye contact instead of speaking while focused on a computer screen. Diagnoses may otherwise be delivered rapidly, while standing or writing prescriptions, with little emotional engagement. The physician says, “You have glaucoma; use this drop”, while the patient internally hears, “You are going blind”. That moment may determine whether the patient enters understanding or fear. Time pressure is real, but even a brief uninterrupted conversation can communicate presence. If we cannot pause for a few minutes to explain a lifelong disease with attention and empathy, it becomes difficult to expect lifelong adherence in return. P - Assessing the Patient’s Perception Before explaining the disease, it is essential to understand what the patient already believes. Questions such as “What have you heard about glaucoma?”, “What worries you the most?”, or “Has anyone in your family lost vision from glaucoma?” can reveal fears, misconceptions, and emotional context. Some patients associate glaucoma with blindness because of a family experience. Others underestimate it because they still see well and have no symptoms. A patient may interpret a red sector on an OCT report as proof of imminent blindness, or assume that a normal central visual acuity means the visual field is unaffected. Not all patients begin from the same emotional or informational starting point. Understanding these perceptions allows the physician to adapt the explanation and address fear before it becomes denial, fatalism, or disengagement. I - Obtaining the Patient’s Invitation Not all information should be delivered at once. Patients process difficult news differently depending on age, personality, emotional state, health literacy, and previous experiences with illness. Asking “Would you like the main message first, or should we review the OCT and visual field step by step?” creates a more collaborative conversation. Even when the answer is “Tell me everything”, the act of asking respects autonomy and restores a sense of control during a vulnerable moment. Invitation does not mean withholding essential information; it guides pacing, depth, and format. When fear limits comprehension, information can be divided into manageable segments and revisited at a follow-up visit. K - Giving Knowledge and Information Information should be delivered clearly, gradually, and without removing hope. In glaucoma, catastrophic language may unintentionally promote fear. Statements such as “There is no cure” or “You will lose vision” can leave patients emotionally paralyzed, especially when no individual context is provided. Communication should remain realistic but proportionate: “Glaucoma can damage vision, but blindness is not inevitable. Your risk depends on the stage, the rate of change, and how the disease responds to treatment. Our goal is to preserve your useful vision for your lifetime”. The physician should distinguish what is known from what remains uncertain. OCT findings can be explained as measurements of optic nerve tissue rather than as a color-coded verdict. Visual field findings should be connected to daily function without treating one unreliable test as proof of progression. Patients should understand that existing nerve damage is generally irreversible, while pressure-lowering treatment can reduce the risk of future loss even when they feel no immediate benefit.4,5 Knowledge also includes the practical reality of treatment: how to instill drops, what adverse effects to expect, what to do when a dose is missed, and when laser or surgery may be considered. Teach-back is more useful than asking “Do you understand?” The physician can say, “I have given you a lot of information. To make sure I explained it clearly, can you tell me what glaucoma means in your case and what our next step will be?” A diagnosis delivered without realistic hope may leave the patient less able to engage. Hope in glaucoma is not a promise that progression will never occur; it is the credible message that risk can be assessed, treatment can be adjusted, and the patient will not face the disease alone. E - Addressing Emotions with Empathy This is where physicians truly begin to “feel through the patient’s eyes”. After hearing the diagnosis, patients may experience fear, silence, disbelief, anger, or sadness. These emotions should not be ignored or rushed. Before returning to technical details, the physician can pause and say, “I understand that this may feel frightening”, “Many people hear glaucoma and immediately think of blindness”, or “You are not alone in this”. Empathy does not require false reassurance. It means recognizing the emotion, naming it when appropriate, and responding to the person before continuing to explain the disease. When distress is persistent, disproportionate, or interferes with daily function, referral for psychological or psychiatric support may be appropriate. Emotional reactions are not always immediate. Many patients process fear only after returning home. They may forget technical details, but they rarely forget how they felt during the conversation. S - Strategy and Summary The conversation should end with direction, not uncertainty. Patients need a clear plan, follow-up structure, and reassurance that they will not face the disease alone. This stage should include explaining the next step, reinforcing follow-up, encouraging questions, checking understanding, and identifying practical or family support. The final message should address the individual plan: whether additional testing is needed, which treatment is recommended, how it should be used, what side effects or costs may create difficulty, and when reassessment will occur. When appropriate, alternatives such as laser or surgery should be discussed, and patient preferences should be incorporated.4,5 Statements such as “We are going to monitor this closely”, “We will adjust treatment if necessary”, and “We are going to work through this together” restore a sense of control. A brief written or digital summary can reinforce the diagnosis, treatment, dosing, follow-up date, and contact pathway for questions. The way the conversation concludes may influence how the patient begins the lifelong work of living with glaucoma. The Role of Family and Social Context Glaucoma is not experienced in isolation. Patients exist within social and family systems that influence how they adapt to chronic disease. Family members may support treatment routines, transportation, appointment attendance, decision-making, and emotional adjustment. They may also transmit fear or misinformation based on another relative’s experience. Recognizing glaucoma as a shared experience allows clinicians, with the patient’s permission, to incorporate trusted family members into the care process. Family involvement should not displace autonomy; the physician should continue to address the patient directly and clarify what information may be shared. The objective is not to include family automatically, but to understand the support system in which the patient will manage the disease. Discussion Ophthalmology has traditionally focused on measurable outcomes such as intraocular pressure, retinal nerve fiber layer thickness, and visual field preservation. These outcomes are essential. Yet glaucoma care ultimately depends on a person repeatedly returning for follow-up, accepting uncertainty, and carrying out a treatment plan that may offer no immediate perceptible benefit. Reframing the delivery of the diagnosis as a therapeutic intervention does not mean that communication lowers intraocular pressure or replaces medical, laser, or surgical treatment. Rather, it recognizes that the diagnostic encounter may reduce avoidable distress, correct misconceptions, strengthen trust, and support engagement with evidence-based care. The available evidence links distress, health beliefs, communication, knowledge, and adherence; medication adherence itself has been associated with visual field progression.8–15,17 However, a direct causal pathway from the first diagnostic conversation to long-term visual outcomes has not been established. Implementation also has limitations. Busy clinics, limited privacy, language differences, low health literacy, fragmented follow-up, and unequal access to medication or testing may restrict what can be accomplished in one visit. SPIKES should therefore not become a rigid script or another checklist that distances the physician from the patient. It can be adapted into a brief core conversation and reinforced by nurses, technicians, educators, written materials, or digital tools. The framework should remain patient-centered rather than protocol-centered. This Perspective is based on a targeted, nonsystematic review, and the supporting literature is heterogeneous. Much of the evidence concerns ongoing glaucoma care, adherence, or communication generally rather than the first diagnostic conversation itself. Although SPIKES has been studied and promoted in ophthalmology, the specific adaptation proposed here has not undergone formal consensus development or prospective validation.6,7 Future research should evaluate feasibility, cultural acceptability, patient comprehension, immediate distress, trust, treatment adherence, and follow-up attendance. Prospective and pragmatic studies are needed to determine whether structured communication at diagnosis produces measurable behavioral or clinical benefits across different healthcare systems, cultural contexts, and resource settings. Conclusion The way glaucoma is diagnosed may influence the trajectory of the patient’s relationship with the disease. When patients feel understood, they may be more likely to engage; when they engage, adherence may become more achievable; and because adherence has been associated with visual field outcomes, that engagement may matter clinically. These relationships should not be interpreted as proof that communication alone changes clinical outcomes. They do, however, support a necessary evolution in glaucoma care: one that recognizes the diagnostic conversation as more than the transfer of information. Delivering the diagnosis with clarity, empathy, structure, and realistic hope may be the first therapeutic act in the lifelong care of a person with glaucoma. Future studies should test that proposition, but scientific caution should not prevent us from seeing the patient, not only the optic nerve, at the center of clinical practice. Disclosure The authors report no conflicts of interest in this work. References